BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12138377)

  • 1. Voriconazole.
    Med Lett Drugs Ther; 2002 Jul; 44(1135):63-5. PubMed ID: 12138377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 3. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole versus amphotericin B for invasive aspergillosis.
    Karthaus M
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 9. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole: review of a broad spectrum triazole antifungal agent.
    Kofla G; Ruhnke M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole: in the treatment of invasive aspergillosis.
    Muijsers RB; Goa KL; Scott LJ
    Drugs; 2002; 62(18):2655-64; discussion 2665-6. PubMed ID: 12466006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the "therapeutic range" for voriconazole?
    Lewis RE
    Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Klont RR; Eggink CA; Rijs AJ; Wesseling P; Verweij PE
    Clin Infect Dis; 2005 Jun; 40(12):e110-2. PubMed ID: 15909252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole versus amphotericin B for invasive aspergillosis.
    Blot F; Edé C; Nitenberg GM
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology and clinical use of voriconazole.
    Thompson GR; Lewis JS
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):83-94. PubMed ID: 19947892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
    J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole: a new triazole antifungal agent.
    Pearson MM; Rogers PD; Cleary JD; Chapman SW
    Ann Pharmacother; 2003 Mar; 37(3):420-32. PubMed ID: 12639175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.